ARK Genomic Revolution ETF

ARKG · ETF

$48.16+$0.29 (+0.61%)TodayMarket closed ·
Prev close $47.87

Latest news

  • NewsChandrima Sanyal

    Cathie Wood's $22M Biotech Shuffle, Dumps One Stock for 21st Straight Session While Other Bets Pile Up

  • NewsChris Katje

    Donald Trump, Cathie Wood Bet on the Same 32 Stocks – Some Might Surprise You

  • NewsChandrima Sanyal

    Cathie Wood Loads Up On Biotech: 5 ETFs Holding Her Latest Bets

  • NewsAkanksha Bakshi

    Why Is Tempus AI Stock Falling Friday?

  • NewsChandrima Sanyal

    Next Biotech Boom May Be Cancer Vaccines: Watch These ETFs

  • NewsVandana Singh

    What’s Going On With Tempus AI Stock on Monday?

  • NewsChandrima Sanyal

    Merck, Moderna Cancer Vaccine Breakthrough Could Be Catalyst the mRNA ETF Trade Has Been Waiting For

  • NewsChandrima Sanyal

    Cathie Wood Swaps Robinhood for SpaceX, Archer—Did ARK Pivot Back to Moonshot Innovation?

  • NewsAkanksha Bakshi

    Tempus AI Slides as Investors Weigh $1.5 Billion Personalis Acquisition

  • NewsVandana Singh

    Why Is Natera Stock Gaining Tuesday?

  • NewsChandrima Sanyal

    Bulls Pile Into Moderna As FDA Decision Nears, Ignites 60% Surge In This ETF

  • NewsChris Katje

    Cathie Wood, Bill Ackman Share 3 Stock Investments In Common: Can You Guess What They Are?

  • NewsShivdeep Dhaliwal

    Cathie Wood Dumps Another $3 Million In AMD Stock As Ark Invest Trims For Third Day Running, This Is the AI Stock She Is Buying Instead

  • NewsShivdeep Dhaliwal

    Cathie Wood Cashes Out Of AMD Again — Sells $8 Million Worth Of Shares, Ark Is Betting On This Nancy Pelosi-Backed AI Stock

  • NewsChris Katje

    Cathie Wood Slams The Brakes — Ark Invest Sits Out As S&P 500 Smashes Records

  • NewsLekha Gupta

    Gilead Expands Partnership With Tempus AI To Power Cancer Discoveries

  • NewsNabaparna Bhattacharya

    Judge Hands Natera 30% Ongoing Royalty In MRD Patent Battle

  • NewsShivdeep Dhaliwal

    Cathie Wood Chooses Medical AI Over Mark Zuckerberg: Ark Loads Up On TEM Stock, Dumps Meta Shares

  • NewsChris Katje

    Cathie Wood Just Bought This Small Cap Stock Seven Days Straight: Should Investors Take Note?

  • NewsChris Katje

    Cathie Wood, Senator Markwayne Mullin Align On These 7 Stock Picks – Some Might Surprise You

  • NewsShivdeep Dhaliwal

    Cathie Wood Is Buying The Tempus AI Dip, Ark Snaps Up Stock Worth $11 Million

  • NewsVandana Singh

    Tempus AI Stock Jumps As Mizuho Starts Coverage, Earnings Scheduled For Next Week

  • NewsAkanksha Bakshi

    Personalis Gets Medicare Coverage For Lung Cancer Surveillance Test

  • NewsShivdeep Dhaliwal

    Cathie Wood Bets Big On AI Trifecta: Ark Deploys $1.4 Million Across Medical, Autonomous Driving Sectors

  • NewsShivdeep Dhaliwal

    Cathie Wood Loads Up On This Robotaxi Stock, Ark Dumps Roku In Latest Trades

  • NewsChris Katje

    Nancy Pelosi's Latest Trades Are Heating Up — Tempus AI's 100% Stock Surge Is Leading The Charge

  • NewsChris Katje

    Cathie Wood Beats S&P 500 in 2025 — This ARK ETF Delivered The Knockout With A 50% Gain

  • NewsChandrima Sanyal

    Biotech ETFs Come Alive As Illumina Soars 23% — Is The Genomics Winter Finally Over?

  • NewsChandrima Sanyal

    Wellgistics Health's 200% Surge Puts AI-Pharma Tie-Ups On The ETF Map

  • NewsAkanksha Bakshi

    Wellgistics And DataVault Team Up To Transform Prescription Tracking

  • NewsChandrima Sanyal

    Trump's Weight-Loss Drug Push May Put These ETFs On A Diet

  • NewsShivdeep Dhaliwal

    Cathie Wood's Ethereum Double-Down: Ark Bets $7.9 Million On ETH-Staking ETF Buy While Selling Coinbase At Highs

  • NewsLekha Gupta

    Schrödinger Scores Big Despite Q3 Miss As Novartis Collaboration Promises Billions In Milestones: Details

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.